SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Europe Spring 2025 Mar 17, 2025–Mar 19, 2025 Milano Italy
Actualités May 11, 2021 Le spécialiste vaudois des traitements ophtalmiques Oculis lève $ 57 millions Oculis, société biopharmaceutique spécialisée dans le développement de traitements ophtalmiques innovants, a annoncé la clôture d’un tour de fina...
Actualités May 10, 2021 Lonza investit CHF 650 millions dans une nouvelle unité de production à Viège Lonza a annoncé un projet d’expansion de ses infrastructures de production cellulaire sur son site de Viège. Les installations seront en place dè...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 Jun 03, 2024–Jun 06, 2024 San Diego United States
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 Jun 03, 2024–Jun 06, 2024 San Diego United States
News Sep 13, 2021 Incyte inaugurates its new production plant in Yverdon After establishing its European headquarters in Morges in 2020, American biopharmaceutical group Incyte strengthens its presence in the canton of...
News Aug 10, 2021 Women’s health biopharmaceutical company ObsEva receives USD 500 million ObsEva, a Geneva-based biopharmaceutical company dedicated to improving women’s reproductive health, will receive up to USD 500 million for the l...
S-GE Event Tomorrow's Health: Meet the Experts on Space & Health Jun 17, 2021 Jun 17, 2021 Online Switzerland
S-GE Event Tomorrow's Health: Meet the Experts on Wearable and Tracking Devices Jun 17, 2021 Jun 17, 2021 Switzerland
S-GE Event Tomorrow's Health: Meet the Experts on Diagnostics and AI Jun 17, 2021 Jun 17, 2021 Switzerland
S-GE Event Tomorrow's Health: Meet the Experts on Patient Data, Empowerment & Blockchain Jun 17, 2021 Jun 17, 2021 Switzerland
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO International Convention 2024 Jun 03, 2024–Jun 06, 2024 San Diego United States